From: Helical TomoTherapy for locally advanced or recurrent breast cancer
Common Toxicity Criteria (CTC) | All patients | Recurrence Treatment Group | Primary Treatment Group |
---|---|---|---|
Radiotherapy | n = 26 | n = 12 | n = 14 |
Radiodermatitis °1 | 14 (53%) | 6 (50%) | 8 (57%) |
Radiodermatitis °2 | 6 (23%) | 4 (33%) | 2 (14%) |
Radiodermatitis °3 | 6 (23%) | 2 (16.7%) | 4 (28%) |
Dysphagia °1 | 10 (%) | 5 (42%) | 5 (36%) |
Lymphedema °3 | 3 (11%) | 4 (33%) | 1 (7%) |
Fatigue | 12 (46%) | 5 (42%) | 7 (50%) |
Chemotherapy | n = 11 | n = 9 | n = 2 |
Leucopenia °1 | 6 (55%) | 5 (55%) | 1 (50%) |
Leucopenia 2 | 5 (42%) | 4 (44%) | 1 (50%) |
Anemia 1 | 6 (55%) | 6 (67%) | − |
Anemia 2 | 3 (27%) | 2 (22%) | 1 (50%) |
Anemia 3 | 1 (9%) | − | 1 (50%) |
Hand-foot-syndrome | 2 (18%) | 2 (22%) | − |